
EQT buys 20% stake in Ottobock
EQT Partners has acquired a 20% stake in German medical technology company Ottobock.
The GP will use capital from EQT VII to make the investment. Ottobock reported revenues of €880m in 2016, leading to a valuation of €3.15bn, according to an EQT press release.
EQT closed its seventh buyout fund EQT VII on its €6.75bn hard-cap in mid-2015, less than six months after launch. The vehicle targets equity investments typically ranging between €125-600m.
Hans Georg Näder will remain majority owner of Ottobock. EQT said it will support Näder and the management team, with a focus on fostering innovation.
Company
Founded in 1919, Ottobock claims to have started the first serial production of prosthetics after the First World War. Today it designs and manufactures medical mobility products including prosthetics, orthotics and wheelchairs.
The company employs more than 7,000 people in 50 countries and reported revenues of €880m in 2016. It invests approximately €56m in research and development annually and has supported the Paralympic games since 1988, joining the International Paralympic Committee in 2005.
People
EQT Partners – Marcus Brennecke (partner).
Ottobock – Hans Georg Näder (president); Harry Wertz (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds